The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Aim
I stand corrected if thats the case for the number of new employees.
I also presume the workload is getting bigger, due to more transactions etc.
The new role expects the new candidate to speak mandarin which bodes well for china coming into play.
along with the website being down and hoping its being re vamped. all seems very positive
Kong
Website still down
Regarding the job news. To my knowledge this is the 3rd job offer that Shane has posted on LinkedIn in recent months. All 3 had similar description. Either the number of employee are growing due to workload or they keep leaving due to whatever reasons.
Time will tell
Kong
Pensioninvestor
You have done nothing wrong.
Like most of us if not all of us on here. We have invested with our due diligence and looked at the previous RNS and noted how boisterous the company was with the potential sells.
One test was passed 2 years ago and the other PSE test was passed in late September.
We anticipated large numbers of sales by now or at least some significant numbers and projections not just one per day per test. That is just totally pathetic.
The management are responsible for this not us
Kong
Wisey
I think you are totally missing the point and have limited business understanding .
I totally agree about taking time to make people aware of a new product.
But may I remind you that the Cirt text has been available for 2 years now !!!!! Burning £800k cash per month needs replenishing..
Burrows made the comment the PSE test was recieving overwhelming demand in the summer.
Where is the demand.
One CB test a day being sold.
So on your points you made . Why didn’t the brains of the management realise how much time was needed and put in place a strategy many many moons ago.
Lastly again on your thoughts and taking time.
Where are Oxford supposed to find the money to keep the doors open .
We had 2 funding rounds in the autumn last year and everyone can see another is urgently needed.
Burrows has said it won’t be that shsreholders get their holdings diluted .
On Burrows previous RNS what’s the chance that ain’t going to happen.
The board are being paid large amounts of money to run this company but I do t see it as a benefit for the shareholder
I just see they are the ones that are benefiting from this debacle
The company has done the science and created the 2 finest tests in the world.
The management should now be focused on selling the product .
They should know the route to sales and they should have been putting salesman or plan or whatever is needed a few months before the test was approved in September.
They did 2 fund raisers in Aug & oct.
The finance director should have made it very clear to the CEO and other directors either directly or on the monthly directors meeting which they do.
He would or should have made it clear, that if they don’t start selling tests fast. Come the first quater of 2024 we will need to raise money again if we don’t start selling big numbers of tests .so why didn’t the CEO put a big selling programme into gear then .
I’m astonished to hear from one or two on here about Burrows hastily mentioning that a salesman went awol in the summer and that’s why sales dipped .
I find the remark very amateur and and astonishing in that it seems to indicate we only had one salesperson.
Burrows has indicated that a deal is imminent without diluting share holder value.
Somehow with false information posted previously, I don’t feel confident that this will be the case.
I also firmly believe that if the company do not start selling large quantities of tests now, we will need another funding round come the end of the year.
An emergency meeting needs to take place and a selling strategy has to be implemented with the utmost urgency
Kong
Wombat
I disagree
yes I understand some people may see these posts that oxford dont want to. But Oxfords top directors have all seen those remarks, They all know we are not happy, thats a fact !!!!!
they all know now we are onto them to sharpen up their act.
at the agm we need to vote with our heads, we may not get the results we wont, but the numbers of votes against what they want will speak volumes
Taverham
I really don`t think the likes of Nigel Farage would be helpfull,
Its all very easy for us armchair business guys to tell everone how to run a business.
But and here I am giving my thoughts. I would have thought Oxford need to get into the department for Health. Surely if they are funding the NHS it is hem that needs to be made aware of the product,
The reason why the test costs what it does and the benefits.
Oxford should have made a costing model to highlight not only the savings it will have created finiancially, but the lives it could possible stop from dying.
Oxford need to target the foundation trusts of the hospitals and the department of health, along with private organisations like Bupa.
All equivalent of the above in the USA and any other country.
Its these organisations that will be buying the tests, not joe public !!!
Kong
I have just listened to a few minutes nothing more of the webinar, and I feel this Burrows bloke is totally inept and out of his depth. He can not communicate on a level that is needed for his position.
He reminds me of used car salesman !!
appears a very arrogant man
This is an extract from the half year report dated 30th MAY 2023 from our CEO, Total lies and manipulation.
Commenting on the results, Dr Jon Burrows, Chief Executive Officer of Oxford BioDynamics, said:
"The first half of our financial year saw excellent progress across the business. There was sustained growth in orders of EpiSwitch CiRT tests, which has continued post-period end. Overwhelming demand for the PSE blood test after announcement of its high accuracy performance led the Group to accelerate its development.
" overwhelming Demand for the PSE test" our CEO reports !!!!!!!
120 days aprox since product launch and aprox 140 tests sold !!!!!
just over 1 per day, not excactly overwhelming demand is it ?
too many snouts in the trough. New management needed with integrity, backbone and HONESTY !!!!
Dibs61
Yes they need another £5 or 10m for another year.
But let’s look at the facts here and try and understand what the problem is .
The CIRT test has been approved aprox 18 months ago and the company is only just selling over 1 a day !!!
The company has had 18 months of trying to sell this test and still a pathetic 1 day
Why ? What is the reason why it’s so bad ? There is an answer, but what is it ?
Only the management know the answer !!!
My question is then, what is going to change in the next 12 months because they need to sell several hundred a week never mind every 18 months !!
The company was boasting about how many millions of men could be tested per year and yet we are talking of only a handful per week
The situation is dire and they have to act now because what they do now will take months for the revenue to start filtering through and time is not on our side
Hi Dug
I too are enligned with your thoughts .
It’s a total and embarrassing situation.
The CEO has to take full responsibility, if he cannot steer this ship correctly he has to go.
To post news that they are only selling one a day of both the finest tests in the world is a total disgrace.
I have been quite vocal on LinkedIn on a couple of their posts and I know the finiancial director has seen my posts as he has viewed my profile
Kong